Light chain (AL) amyloidosis is a disease in which clonal plasma cells produce misfolded
light chains that then deposit in organs and impair their function. Amyloidosis is a …

Light chain amyloidosis is a plasma–cell disorder with a poor prognosis. It is a progressive
condition, causing worsening pain, disability, and life-limiting complications involving …

The immunoglobulin light-chain amyloidosis is a multisystemic disease which manifests by
damage to the vital organs by light chain-derived amyloid fibril. Traditionally, the treatment …

Immunoglobulin light chain (AL) amyloidosis is a disorder of clonal plasma cells
characterized by deposition of amyloid fibrils in a variety of tissues, leading to end-organ …

Abstract Abstract 3109 Background: High dose melphalan (MEL) is a standard treatment for
eligible patients with AL, a disease in which hematologic response is a key determinant of …

Light chain (AL) amyloidosis is a rare plasma cell dyscrasia. An estimated 12,000 people
live with the disease in the United States. AL amyloidosis occurs from the misfolding of …

The role of consolidation post autologous stem cell transplant in light chain amyloidosis is
not well defined. We retrospectively identified patients who had light chain amyloidosis and …

Immunoglobulinh light chain (AL) amyloidosis is a plasma cell dyscrasia characterized by
the overproduction and tissue deposition of monoclonal immunoglobulin light chains which …

Immunoglobulin light chain amyloidosis (AL amyloidosis) is a plasma cell disorder leading
to the production and extracellular deposition of abnormal immunoglobulin light chains …

Immunoglobulin light-chain (AL) amyloidosis is a systemic disease characterized by the
production and deposition of light chain-derived amyloid fibrils in different organs. Prompt …